1
|
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis. J Addict Med 2022; 16:630-638. [PMID: 35653782 PMCID: PMC10010623 DOI: 10.1097/adm.0000000000000992] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND We aimed to determine medications' comparative efficacy and safety for adults with alcohol use disorders. METHODS We searched eleven electronic data sources for randomized clinical trials with at least 4 weeks of treatment reporting on alcohol consumption (total abstinence and reduced heavy drinking), dropouts, and dropouts due to adverse events. We conducted network meta-analyses using random-effects, frequentist models, and calculated summary rate ratios (RRs) with 95% confidence intervals (CIs). RESULTS We included 156 trials (N = 27,334). Nefazodone (RR = 2.11; 95% CI, 1.42-3.13), aripiprazole (RR = 1.97; 95% CI, 1.36-2.88), carbamazepine (RR = 1.85; 95% CI, 1.03-3.32), and nalmefene (RR = 1.17; 95% CI, 1.01-1.35) were associated with the most dropouts. Baclofen (RR = 0.83; 95% CI, 0.70-0.97) and pregabalin (RR = 0.63; 95% CI, 0.43-0.94) caused fewer dropouts than placebo. Nalmefene (RR = 3.26; 95% CI, 2.34-4.55), fluvoxamine (RR = 3.08; 95% CI, 1.59-5.94), and topiramate (RR=2.18; 95% CI, 1.36-3.51) caused more dropouts from adverse events over placebo. Gamma-hydroxy-butyrate (RR = 1.90; 95% CI, 1.03-3.53), baclofen (RR = 1.80; 95% CI, 1.39-2.34), disulfiram (RR = 1.71; 95% CI, 1.39-2.10), gabapentin (RR = 1.66; 95% CI, 1.04-2.67), acamprosate (RR = 1.33; 95% CI, 1.15-1.54), and oral naltrexone (RR = 1.15; 95% CI, 1.01-1.32) improved total abstinence over placebo (Fig. 3C). For reduced heavy drinking, disulfiram (RR = 0.19; 95% CI, 0.10-0.35), baclofen (RR = 0.72; 95% CI, 0.57-0.91), acamprosate (RR = 0.78; 95% CI, 0.70-0.86), and oral naltrexone (RR = 0.81; 95% CI, 0.73-0.90) were efficacious against placebo. CONCLUSIONS The current meta-analyses provide evidence that several medications for AUDs are effective and safe and encourage the expanded use of these medications in the clinical setting. Our review found that acamprosate (2-3 g/d), disulfiram (250-500 mg/d), baclofen (30 mg/d), and oral naltrexone (50 mg/d) had the best evidence for improving abstinence and heavy drinking for patients with AUD. PROSPERO CRD42020208946.
Collapse
|
2
|
Staton CA, Vissoci JRN, El-Gabri D, Adewumi K, Concepcion T, Elliott SA, Evans DR, Galson SW, Pate CT, Reynolds LM, Sanchez NA, Sutton AE, Yuan C, Pauley A, Andrade L, Von Isenberg M, Ye JJ, Gerardo CJ. Patient-level interventions to reduce alcohol-related harms in low- and middle-income countries: A systematic review and meta-summary. PLoS Med 2022; 19:e1003961. [PMID: 35413054 PMCID: PMC9004752 DOI: 10.1371/journal.pmed.1003961] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Accepted: 03/09/2022] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND Disease and disability from alcohol use disproportionately impact people in low- and middle-income countries (LMICs). While varied interventions have been shown to reduce alcohol use in high-income countries, their efficacy in LMICs has not been assessed. This systematic review describes current published literature on patient-level alcohol interventions in LMICs and specifically describes clinical trials evaluating interventions to reduce alcohol use in LMICs. METHODS AND FINDINGS In accordance with PRISMA, we performed a systematic review using an electronic search strategy from January 1, 1995 to December 1, 2020. Title, abstract, as well as full-text screening and extraction were performed in duplicate. A meta-summary was performed on randomized controlled trials (RCTs) that evaluated alcohol-related outcomes. We searched the following electronic databases: PubMed, EMBASE, Scopus, Web of Science, Cochrane, WHO Global Health Library, and PsycINFO. Articles that evaluated patient-level interventions targeting alcohol use and alcohol-related harm in LMICs were eligible for inclusion. No studies were excluded based on language. After screening 5,036 articles, 117 articles fit our inclusion criteria, 75 of which were RCTs. Of these RCTs, 93% were performed in 13 middle-income countries, while 7% were from 2 low-income countries. These RCTs evaluated brief interventions (24, defined as any intervention ranging from advice to counseling, lasting less than 1 hour per session up to 4 sessions), psychotherapy or counseling (15, defined as an interaction with a counselor longer than a brief intervention or that included a psychotherapeutic component), health promotion and education (20, defined as an intervention encouraged individuals' agency of taking care of their health), or biologic treatments (19, defined as interventions where the biological function of alcohol use disorder (AUD) as the main nexus of intervention) with 3 mixing categories of intervention types. Due to high heterogeneity of intervention types, outcome measures, and follow-up times, we did not conduct meta-analysis to compare and contrast studies, but created a meta-summary of all 75 RCT studies. The most commonly evaluated intervention with the most consistent positive effect was a brief intervention; similarly, motivational interviewing (MI) techniques were most commonly utilized among the diverse array of interventions evaluated. CONCLUSIONS Our review demonstrated numerous patient-level interventions that have the potential to be effective in LMICs, but further research to standardize interventions, populations, and outcome measures is necessary to accurately assess their effectiveness. Brief interventions and MI techniques were the most commonly evaluated and had the most consistent positive effect on alcohol-related outcomes. TRIAL REGISTRATION Protocol Registry: PROSPERO CRD42017055549.
Collapse
Affiliation(s)
- Catherine A. Staton
- Duke Division of Emergency Medicine, Department of Surgery, Duke University Medical Center, Duke University, Durham, North Carolina, United States of America
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
- Health Sciences Graduate Program, State University of Maringa, Maringa, Parana State, Brazil
| | - João Ricardo Nickenig Vissoci
- Duke Division of Emergency Medicine, Department of Surgery, Duke University Medical Center, Duke University, Durham, North Carolina, United States of America
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
- Health Sciences Graduate Program, State University of Maringa, Maringa, Parana State, Brazil
| | - Deena El-Gabri
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Konyinsope Adewumi
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Tessa Concepcion
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Shannon A. Elliott
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Daniel R. Evans
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Sophie W. Galson
- Duke Division of Emergency Medicine, Department of Surgery, Duke University Medical Center, Duke University, Durham, North Carolina, United States of America
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Charles T. Pate
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Lindy M. Reynolds
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Nadine A. Sanchez
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Alexandra E. Sutton
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
- Nicholas School of the Environment, Duke University, Durham, North Carolina, United States of America
| | - Charlotte Yuan
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Alena Pauley
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| | - Luciano Andrade
- Health Sciences Graduate Program, State University of Maringa, Maringa, Parana State, Brazil
| | - Megan Von Isenberg
- Duke School of Medical Center Library Services & Archives, Duke University, Durham, North Carolina, United States of America
| | - Jinny J. Ye
- Duke Division of Emergency Medicine, Department of Surgery, Duke University Medical Center, Duke University, Durham, North Carolina, United States of America
| | - Charles J. Gerardo
- Duke Division of Emergency Medicine, Department of Surgery, Duke University Medical Center, Duke University, Durham, North Carolina, United States of America
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America
| |
Collapse
|